Patients with a history of hypersensitivity to thymosin α1 or any component of the injection. Because Zadaxin therapy appears to work by enhancing the immune system, it should be considered contraindicated in patients who are being deliberately immunosuppressed, for instance transplant patients, unless the potential benefits of the therapy clearly outweigh the potential risks.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
